We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Migraine Episodes Linked to Parkinson's Disease Risk

By HospiMedica International staff writers
Posted on 21 Feb 2016
Suffering two migraine diagnoses in the space of one year is associated with a greater risk of developing Parkinson's disease (PD) three years later, according to a new study.

Researchers at National Taiwan University Hospital (Taipei) conducted a longitudinal population-based study involving 41,019 subjects (40–90 years of age) with at least two ambulatory visits with a diagnosis of migraine during the year 2001; the control group consisted of 41,019 migraine-free randomly sampled subjects matched by sex, age, comorbidity, and socioeconomic data. More...
The researchers then measured PD-free survival rate and estimated the effect of migraine presence on the risk of developing PD.

The results showed that during a median 32-month follow-up, 148 patients in the migraine group and 101 patients in the non-migraine group were diagnosed with PD, suggesting a statistically significant increase in risk for those with migraine. The researchers listed several explanations for the results, suggesting that both migraines and PD could be the result of serotonergic and dopaminergic system dysfunction, or that both ailments could arise from dysfunctional iron metabolism in the brain. The study was published on February 6, 2016, in Cephalalgia.

“Since this study is an observational study, it is subject to confounding effects arising from imbalance in clinical characteristics between patients with and without migraine. These findings may highlight the importance of early risk assessment for Parkinson's disease in migraineurs,” said senior author Prof. Shin-Liang Pan, MD, PhD. “Future longitudinal studies with neuroimaging and neurologic examinations are needed in order to elucidate the relationship and the underlying pathophysiological mechanism between migraine and Parkinson's disease.”

Migraine is a debilitating condition characterized by moderate to severe headaches, and is about three times more common in women than in men. The typical migraine headache is aggravated by routine activity, and is unilateral and pulsating in nature, lasting from 4 to 72 hours. Symptoms include nausea, vomiting, photophobia, and phonophobia. Approximately one-third of people who suffer from migraine headaches perceive an aura—an unusual visual, olfactory, or other sensory experience that is a sign that the migraine will soon occur.

Related Links:

National Taiwan University Hospital




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.